SCHEMBL7984472

SCHEMBL7984472

Fc1cccc(Cl)c1Nc1nc2ccc(-n3ccnc3)cc2n2cncc12

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983230 0.82 LCK (0.77) LCK
SCHEMBL7981276 0.81 LCK (0.82) LCK
SCHEMBL7969934 0.79 LCK (0.82) LCK
SCHEMBL8468808 0.79 LCK (0.61) LCK
SCHEMBL7987285 0.79 LCK (0.80) LCK
SCHEMBL7983379 0.78 LCK (0.85) LCK
SCHEMBL8468839 0.78 LCK (0.83) LCK
SCHEMBL8468894 0.76 LCK (0.75) LCK
SCHEMBL7984212 0.76 NCOA3 (0.47)
SCHEMBL8470154 0.75 LCK (0.73) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO disclosed